Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization

Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization

BackgroundThe inclusion of immune checkpoint inhibitors (ICIs) in therapeutic algorithms has led to significant survival benefits in patients with various metastatic cancers. Concurrently, an increasing number of neurological immune related adverse events (IRAE) has been observed. In this retrospect...

Full description

Bibliographic Details
Main Authors:	Hans Urban, Eike Steidl, Elke Hattingen, Katharina Filipski, Markus Meissner, Martin Sebastian, Agnes Koch, Adam Strzelczyk, Marie-Thérèse Forster, Peter Baumgarten, Michael W. Ronellenfitsch, Joachim P. Steinbach, Martin Voss
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Immunology
Subjects:	immune checkpoint inhibitors (ICI) immunotherapy cerebral pseudoprogression immune related adverse events (irAE) brain metastases neurological side effects
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.798811/full

Similar Items

Longitudinal study on MRI and neuropathological findings: Neither DSC-perfusion derived rCBVmax nor vessel densities correlate between newly diagnosed and progressive glioblastoma
by: Eike Steidl, et al.
Published: (2023-01-01)

Single-shot bevacizumab for cerebral radiation injury
by: Martin Voss, et al.
Published: (2021-02-01)

Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition
by: Hans Urban, et al.
Published: (2020-01-01)

Neurocognitive Outcome and Seizure Freedom After Awake Surgery of Gliomas
by: Sarah Christina Reitz, et al.
Published: (2022-04-01)

Pulmonary Resection after Radiosurgery and Neoadjuvant Immunochemotherapy for NSCLC Patients with Synchronous Brain Metastasis—A Case Series of Three Patients
by: Agnes Koch, et al.
Published: (2022-03-01)

Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy.
by: Elke Hattingen, et al.
Published: (2013-01-01)

Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide
by: Nadja I. Lorenz, et al.
Published: (2021-07-01)

Status epilepticus in patients with brain tumors and metastases: A multicenter cohort study of 208 patients and literature review
by: Johanna K. Rickel, et al.
Published: (2024-04-01)

Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death
by: Benedikt Sauer, et al.
Published: (2024-01-01)

Inhibition of mTOR signaling protects human glioma cells from hypoxia-induced cell death in an autophagy-independent manner
by: Iris Divé, et al.
Published: (2022-10-01)

Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1
by: Sven König, et al.
Published: (2024-08-01)

Magnetic Resonance Imaging as the Primary Imaging Modality in Children Presenting with Inflammatory Nontraumatic Atlantoaxial Rotatory Subluxation
by: Katharina J. Wenger, et al.
Published: (2021-04-01)

Qualitative and quantitative detectability of hypertrophic olivary degeneration in T2, FLAIR, PD, and DTI: A prospective MRI study
by: Eike Steidl, et al.
Published: (2022-08-01)

Immunohistochemical Assessment of Phosphorylated mTORC1-Pathway Proteins in Human Brain Tumors.
by: Patrick N Harter, et al.
Published: (2015-01-01)

Impact and risk factors of red blood cell transfusion on patients undergoing elective primary meningioma resection
by: V. Neef, et al.
Published: (2021-01-01)

Forms of Non-Apoptotic Cell Death and Their Role in Gliomas—Presentation of the Current State of Knowledge
by: Reinhold Nafe, et al.
Published: (2024-07-01)

Cellular Components of the Tumor Environment in Gliomas—What Do We Know Today?
by: Reinhold Nafe, et al.
Published: (2023-12-01)

The Spectrum of Molecular Pathways in Gliomas—An Up-to-Date Review
by: Reinhold Nafe, et al.
Published: (2023-08-01)

The impact of referring patients with drug-resistant focal epilepsy to an epilepsy center for presurgical diagnosis
by: Leonhard Mann, et al.
Published: (2023-12-01)

Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy
by: Mueller-Klieser Wolfgang, et al.
Published: (2011-07-01)

Detection of diagnostic somatic copy number alterations from cerebrospinal fluid cell-free DNA in brain tumor patients
by: Svenja Klinsing, et al.
Published: (2024-11-01)

Prevalence of acute neurological complications and pathological neuroimaging findings in critically ill COVID-19 patients with and without VV-ECMO treatment
by: Angelo Ippolito, et al.
Published: (2022-10-01)

Human prion diseases and the prion protein – what is the current state of knowledge?
by: Nafe Reinhold, et al.
Published: (2023-10-01)

Fenfluramine for the treatment of status epilepticus: use in an adult with Lennox–Gastaut syndrome and literature review
by: Adam Strzelczyk, et al.
Published: (2024-02-01)

A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1
by: Kai Zhao, et al.
Published: (2024-04-01)

Pseudoprogression and hyperprogression secondary to immunotherapy in lung cancer
by: R. Riera-Sala, et al.
Published: (2023-09-01)

Spectral Design of Active Mechanical and Electrical Metamaterials
by: Ronellenfitsch, Henrik Michael, et al.
Published: (2021)

Chiral Topological Phases in Designed Mechanical Networks
by: Ronellenfitsch, Henrik Michael, et al.
Published: (2020)

Characterization of MRI White Matter Signal Abnormalities in the Pediatric Population
by: Katharina J. Wenger, et al.
Published: (2023-01-01)

The influence of endothelial hyperplasia on pseudoprogression development in patients with glioblastoma
by: Petrović Marko, et al.
Published: (2019-01-01)

Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acid.
by: Sebastian Fischer, et al.
Published: (2014-01-01)

An AMP‐activated protein kinase‐PGC‐1α axis mediates metabolic plasticity in glioblastoma
by: Benedikt Sauer, et al.
Published: (2024-11-01)

Pseudoprogression; discussion of the concept of pseudoprogression on the characteristics of tomographic changes in liver metastases of colorectal cancer patients receiving bevacizumab therapy
by: Pinar Ozdemir Akdur, et al.
Published: (2023-09-01)

Optimal Noise-Canceling Networks
by: Wilczek, Michael, et al.
Published: (2018)

BUILDING THE MUSEUM CULTURE OF STUDENTS AND PUPILS THROUGH MUSEUM EXHIBITIONS IN THE INFORMATION TECHNOLOGIES ERA
by: FILIPSKI, Tatiana
Published: (2023-10-01)

VISUAL ARTS EDUCATION FOR DESIGN STUDENTS FROM THE PERSPECTIVE OF MUSEUM EDUCATION IN A SOCIAL CONTEXT
by: FILIPSKI, Tatiana
Published: (2024-06-01)

MUZEUL CA INSTITUȚIE FUNDAMENTALĂ DE REALIZARE A EDUCAȚIEI MUZEALE: DELIMITĂRI CONCEPTUALE
by: Tatiana FILIPSKI
Published: (2019-10-01)

The Potential Use of Radiomics with Pre-Radiation Therapy MR Imaging in Predicting Risk of Pseudoprogression in Glioblastoma Patients
by: Michael Baine, et al.
Published: (2021-01-01)

Pseudoprogression Disease in a Patient with Small Cell Lung Cancer on Immune Checkpoint Inhibitor Therapy
by: Zhu W, et al.
Published: (2023-09-01)

Multicenter Prospective Analysis of Hypertrophic Olivary Degeneration Following Infratentorial Stroke (HOD-IS): Evaluation of Disease Epidemiology, Clinical Presentation, and MR-Imaging Aspects
by: Martin A. Schaller-Paule, et al.
Published: (2021-07-01)